MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 44 filers reported holding MYMD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,569 | +12.4% | 171,570 | +184.8% | 0.01% | 0.0% |
| Q2 2023 | $90,353 | -15.2% | 60,235 | -2.8% | 0.01% | -11.1% |
| Q1 2023 | $106,564 | +34.6% | 61,956 | -10.0% | 0.01% | +28.6% |
| Q4 2022 | $79,166 | -53.7% | 68,840 | +5.3% | 0.01% | -61.1% |
| Q3 2022 | $171,000 | – | 65,398 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 139,986 | $365,000 | 0.08% |
| Taylor & Morgan Wealth Management, LLC | 17,086 | $45,000 | 0.04% |
| Bridgecreek Investment Management, LLC | 65,000 | $170,000 | 0.04% |
| Corundum Group, Inc. | 19,600 | $51,000 | 0.03% |
| Aaron Wealth Advisors LLC | 50,000 | $131,000 | 0.02% |
| M Holdings Securities, Inc. | 70,909 | $185,000 | 0.02% |
| Cambria Investment Management, L.P. | 65,398 | $171,000 | 0.02% |
| Praetorian Wealth Management, Inc. | 15,000 | $39,000 | 0.02% |
| Mirae Asset Global Investments Co., Ltd. | 638,580 | $1,667,000 | 0.00% |
| Western Wealth Management, LLC | 25,050 | $71,000 | 0.00% |